ClinicalTrials.Veeva

Menu

Neurodevelopmental Therapy for Spastic Cerebral Palsy (NDT)

U

University of Lahore

Status

Completed

Conditions

Spastic
Cerebral Palsy
Diplegia, Spastic

Treatments

Other: Routine physical therapy
Other: Neurodevelopmental therapy

Study type

Interventional

Funder types

Other

Identifiers

NCT05231538
IRB-UOL-FAHS/882/2021

Details and patient eligibility

About

This study was conducted to find out the Effects of Neurodevelopment therapy (a rehabilitative program designed by Bobath) on Gross Motor Function and Postural Control in Children with Spastic Cerebral Palsy. To investigate either there was a significant difference between the effects of neurodevelopment therapy and routine physical therapy on gross motor function and postural control in children with Spastic Cerebral Palsy.

Full description

A randomized controlled trial was conducted at Department of pediatric rehabilitation, Sher e Rabbani Hospital, Sheikhupura. Sample size was 66 and purposive sampling technique was adopted to collect data. Sample selection was completely based on inclusion and exclusion criteria. A diagnosed Spastic Cerebral Palsy patient aged 2-6 years with no other severe abnormalities such as seizure were recruited. While patients with mental retardation or undergone medical procedures likely to affect motor function such as botulinum toxin injections, orthopedic remedial surgery were excluded. Data was collected at baseline, 4th, 8th and 12th week of the treatment sessions. Gross motor function measure scale (GMFM-88) and posture and postural ability scale (PPAS) were used as data collection tools.

Enrollment

66 patients

Sex

All

Ages

2 to 6 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • • A diagnosed Spastic Cerebral Palsy (patient's diagnosis of CP confirmed by an expert pediatrician neurologist)

    • Spastic CP
    • No other severe abnormalities such as seizure
    • Aged 2-6 years
    • Both Genders

Exclusion criteria

  • Medical procedures likely to affect motor function such as botulinum toxin injections
  • Orthopedic remedial surgery
  • Mental retardation, or a learning disability.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

66 participants in 2 patient groups

Neurodevelopmental Therapy
Experimental group
Description:
The treatment group received neurodevelopment treatment lasting for 3 months (3sessions per week). Additionally, for this study, the NDT programme included passive stretching of the lower limb muscles (e.g. hamstrings, gastrocsoleus), followed by techniques of reducing spasticity and facilitating more normal patterns of movement while working on motor functions. In each session, exercises included patients sustaining themselves on their forearms and hands, sitting, crawling, semi-kneeling, and in standing positions supported by the Physical therapist until tone reduction achieved. Balance and corrective reactions were developed by using a CP ball and tilt board.
Treatment:
Other: Neurodevelopmental therapy
Routine Physical Therapy
Active Comparator group
Description:
The control group underwent the exercises (stretching, passive range of motion, and active range of motion).
Treatment:
Other: Routine physical therapy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems